These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Estimated glucose requirement following massive insulin overdose in a patient with type 1 diabetes. Fasching P; Roden M; Stühlinger HG; Kurzemann S; Zeiner A; Waldhäusl W; Laggner AN Diabet Med; 1994 Apr; 11(3):323-5. PubMed ID: 8033534 [TBL] [Abstract][Full Text] [Related]
3. Suicidal insulin overdose in a type 1 diabetic patient: relation of serum insulin concentrations to the duration of hypoglycemia. Shibutani Y; Ogawa C J Diabetes Complications; 2000; 14(1):60-2. PubMed ID: 10925068 [TBL] [Abstract][Full Text] [Related]
4. Octreotide for the treatment of intentional insulin aspart overdose in a non-diabetic patient. Dewaal CM; McGillis E; Mink M; Lucyk S CJEM; 2018 Jul; 20(4):643-647. PubMed ID: 29202888 [TBL] [Abstract][Full Text] [Related]
5. Duration of hypoglycemia and need for intravenous glucose following intentional overdoses of insulin. Stapczynski JS; Haskell RJ Ann Emerg Med; 1984 Jul; 13(7):505-11. PubMed ID: 6377986 [TBL] [Abstract][Full Text] [Related]
6. Lantus insulin overdose: a case report. Lu M; Inboriboon PC J Emerg Med; 2011 Oct; 41(4):374-7. PubMed ID: 20493654 [TBL] [Abstract][Full Text] [Related]
7. Prolonged hypoglycaemia after insulin lispro overdose. Brvar M; Mozina M; Bunc M Eur J Emerg Med; 2005 Oct; 12(5):234-5. PubMed ID: 16175061 [TBL] [Abstract][Full Text] [Related]
8. Intentional overdose with insulin glargine and insulin aspart. Tofade TS; Liles EA Pharmacotherapy; 2004 Oct; 24(10):1412-8. PubMed ID: 15628838 [TBL] [Abstract][Full Text] [Related]
9. Intentional massive insulin overdose: recognition and management. Roberge RJ; Martin TG; Delbridge TR Ann Emerg Med; 1993 Feb; 22(2):228-34. PubMed ID: 8427437 [TBL] [Abstract][Full Text] [Related]
10. A Case Involving Massive Insulin Overdose: Direct and Indirect Conditions Requiring Extended Management of Serum Potassium. Miyakuni Y; Nakajima M; Kaszynski RH; Tarui T; Goto H; Yamaguchi Y Am J Case Rep; 2020 Mar; 21():e920078. PubMed ID: 32179729 [TBL] [Abstract][Full Text] [Related]
11. Poisoning with insulin glargine. Brvar M; Mozina M; Bunc M Clin Toxicol (Phila); 2005; 43(3):219-20. PubMed ID: 15902802 [No Abstract] [Full Text] [Related]
12. Management of intentional overdose of insulin glargine. Kumar A; Hayes CE; Iwashyna SJ; Boustani R; Duncan L; Mickell JJ; Francis G Endocrinol Nutr; 2012 Nov; 59(9):570-2. PubMed ID: 22425479 [No Abstract] [Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Lepore M; Pampanelli S; Fanelli C; Porcellati F; Bartocci L; Di Vincenzo A; Cordoni C; Costa E; Brunetti P; Bolli GB Diabetes; 2000 Dec; 49(12):2142-8. PubMed ID: 11118018 [TBL] [Abstract][Full Text] [Related]
17. Intravenous glucagon in a deliberate insulin overdose in an adolescent with type 1 diabetes mellitus. White M; Zacharin MR; Werther GA; Cameron FJ Pediatr Diabetes; 2016 Feb; 17(1):66-9. PubMed ID: 25229989 [TBL] [Abstract][Full Text] [Related]
18. Dilemma of diagnosing sulphonylurea overdose in children: deliberations and considerations before reaching a diagnosis. Gopal-Kothandapani JS; Wright KP; Sithambaram S; Natarajan A BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28847991 [TBL] [Abstract][Full Text] [Related]
20. Different absorption of isophane (NPH) insulin from subcutaneous and intramuscular sites suggests a need to reassess recommended insulin injection technique. Thow JC; Johnson AB; Fulcher G; Home PD Diabet Med; 1990 Aug; 7(7):600-2. PubMed ID: 2146067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]